 Moneycontrol.com | Buy Biocon; target of Rs 320: Unicon Investment Moneycontrol.com Immuno-suppressants grew by 40% YoY backed by strong Tacrolimus and MMF sales. Contract research services vertical posted a robust growth of 42% YoY. Biopharmaceutical division which includes LI remained down 13%. However in constant currency terms, ... |
